Arcadia has built a portfolio of over-the-counter medicines and wellness brands, including Nizoral, Colace, Senokot, CloSYS, Betadine, and Kaopectate. During Mubadala's investment period, the company's revenue tripled and profitability improved materially. 'It has been a privilege to partner with Bansk, Mike DeBiasi and the Arcadia team over the past four years,' Philip Yifei Bao, director of private equity at Mubadala, said in a statement. 'We are incredibly proud to have supported the transformation of Arcadia into the leading North American consumer health and wellness platform.' Subscribe to our Newsletter to increase your edge. Don't worry about the news anymore, through our newsletter you'll receive weekly access to what is happening. Join 120,000 other PE professionals today.
learn more
